Anchorage Capital has moved on to greater things after DSE... http://www.smh.com.au/nsw/its-shock...g-profits-from-childcare-20161117-gsrjuq.html
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%